Cross-Site Scripting Vulnerability in IBM TRIRIGA
CVE-2016-9737

5.4MEDIUM

Key Information:

Vendor

IBM
Status
Tririga Application Platform
Vendor
CVE Published:
27 March 2017

What is CVE-2016-9737?

IBM TRIRIGA versions 3.3, 3.4, and 3.5 are susceptible to a cross-site scripting vulnerability. This issue enables an attacker to inject arbitrary JavaScript into the Web UI, potentially altering its functionality. This can lead to credential disclosure during trusted user sessions, posing significant risks to data security. For further details, refer to IBM's support documentation and the SecurityFocus advisory.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

TRIRIGA Application Platform 3.2

TRIRIGA Application Platform 3.2.1

TRIRIGA Application Platform 3.1

References

http://www.ibm.com/support/docview.wss?uid=swg21996200
x_refsource_CONFIRM
http://www.securityfocus.com/bid/97064
vdb-entryx_refsource_BID

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.